Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Slowing ribosome velocity restores folding and function of mutant CFTR.  Journal of Clinical Investigation.  129:5236-5253. 2019
2019 A humanized yeast phenomic model of deoxycytidine kinase to predict genetic buffering of nucleoside analog cytotoxicity.  Genes.  10. 2019
2019 A humanized yeast phenomic model of deoxycytidine kinase to predict genetic buffering of nucleoside analog cytotoxicity 2019
2019 A yeast phenomic model for the influence of Warburg metabolism on genetic buffering of doxorubicin 2019
2019 A yeast phenomic model for the influence of Warburg metabolism on genetic buffering of doxorubicin..  Cancer & Metabolism.  7:9. 2019
2016 Gene-nutrient interaction markedly influences yeast chronological lifespan.  Experimental Gerontology.  86:113-123. 2016
2016 Ribosomal Stalk Protein Silencing Partially Corrects the ΔF508-CFTR Functional Expression Defect.  PLoS Biology.  14. 2016
2016 Long-range coupling between the extracellular gates and the intracellular ATP binding domains of multidrug resistance protein pumps and cystic fibrosis transmembrane conductance regulator channels.  The FASEB Journal.  30:1247-1262. 2016
2015 Yeast phenomics: An experimental approach for modeling gene interaction networks that buffer disease.  Genes.  6:24-45. 2015
2014 Aging and energetics' 'Top 40' future research opportunities 2010-2013.  F1000Research.  3. 2014
2014 Conserved allosteric hot spots in the transmembrane domains of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) channels and Multidrug Resistance Protein (MRP) pumps.  Journal of Biological Chemistry.  289:19942-19957. 2014
2014 Phenomic assessment of genetic buffering by kinetic analysis of cell arrays.  Methods in Molecular Biology.  1205:187-208. 2014
2013 The SWI/SNF Chromatin Remodeling Complex Influences Transcription by RNA Polymerase I in Saccharomyces cerevisiae.  PLoS ONE.  8. 2013
2012 A yeast phenomic model for the gene interaction network modulating CFTR-ΔF508 protein biogenesis 2012
2011 A screen to identify small molecule inhibitors of protein-protein interactions in mycobacteria.  ASSAY and Drug Development Technologies.  9:299-310. 2011
2010 Global analysis of phase locking in gene expression during cell cycle: The potential in network modeling.  BMC Systems Biology.  4. 2010
2010 Recursive expectation-maximization clustering: A method for identifying buffering mechanisms composed of phenomic modules 2010
2009 Genomewide analysis reveals novel pathways affecting endoplasmic eticulum homeostasis, protein modification and quality control 2009
2009 Stringent mating-type-regulated auxotrophy increases the accuracy of systematic genetic interaction screens with Saccharomyces cerevisiae mutant arrays 2009
2008 Defining genetic interaction 2008
2007 Buffering of deoxyribonucleotide pool homeostasis by threonine metabolism 2007
2007 High throughput drug screening for human immunodeficiency virus type 1 reactivating compounds.  ASSAY and Drug Development Technologies.  5:181-189. 2007
2007 Accurate, precise modeling of cell proliferation kinetics from time-lapse imaging and automated image analysis of agar yeast culture arrays.  BMC Systems Biology.  1. 2007
2005 The case for strategic international alliances to harness nutritional genomics for public and personal health 2005
2005 The case for strategic international alliances to harness nutritional genomics for public and personal health 2005
2004 Systematic quantification of gene interactions by phenotypic array analysis..  Genome Biology.  5. 2004
2001 Cell Biology: Principles for the buffering of genetic variation.  Science.  291:1001-1004. 2001
1996 Functional reconstitution in situ of 5-hydroxytryptamine(2c) (5HT(2c)) receptors with α(q) and inverse agonism of 5HT(2c) receptor antagonists.  Journal of Biological Chemistry.  271:22591-22597. 1996
1994 Cystic fibrosis transmembrane conductance regulator mutations that disrupt nucleotide binding.  Journal of Clinical Investigation.  94:228-236. 1994
1992 Affinity purification of insoluble recombinant fusion proteins containing glutathione‐S‐transferase.  Biotechnology and Bioengineering.  39:828-832. 1992
1992 Hypothyroidism in adults with sickle cell anemia.  American Journal of Medicine.  92:567-570. 1992
1992 Hypothyroidism in adults with sickle cell anemia.  American Journal of Medicine.  92:567-570. 1992
1992 Intrinsic anion channel activity of the recombinant first nucleotide binding fold domain of the cystic fibrosis transmembrane regulator protein 1992
1992 Recombinant synthesis, purification, and nucleotide binding characteristics of the first nucleotide binding domain of the cystic fibrosis gene product.  Journal of Biological Chemistry.  267:6455-6458. 1992
1990 Regulation of Tissue Plasminogen Activator in Sickle Cell Anemia.  American Journal of Hematology.  35:167-170. 1990
1988 Totally implantable intravenous catheters in the management of sickle cell anemia.  American Journal of Hematology.  29:134-138. 1988
1988 Chronic granulocytic leukemia in a patient with sickle cell anemia.  American Journal of Medicine.  85:567-569. 1988
High-resolution yeast quiescence profiling in human-like media reveals interacting influences of auxotrophy and nutrient availability
Nutritional Genomics: Discovering the Path to Personalized Nutrition

Chapter

Year Title Altmetric
2006 Genetic and Molecular Buffering of Phenotypes.  105-134. 2006

Principal Investigator On

Investigator On

Education And Training

  • Doctor of Medicine, University of Alabama at Birmingham 1995
  • Bachelor of Science or Mathematics in Zoological Medicine Residency Program, Duke University 1989

    • Full Name

  • John Hartman